The prospect of targeting inflammation to treat residual cardiovascular risk using the monoclonal antibody canakinumab (Ilaris) appears to be slim to none in the wake of recent decisions from ...
We analysed the past 20 years of drug project history with the aim of understanding more about how the pharmaceutical industry has been performing with regard to therapeutic mechanisms and their ...
Figure 2: Enrichment of target genes for drugs approved in the United States or the European Union. Figure 3: Overlap between drug targets and their indications with genetic associations for similar ...
FDA final guidance titled Medical Devices with Indications Associated with Weight Loss – Premarket Considerations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results